Neurodegeneration, the continuous decline in the health of nerves, presents a serious challenge to modern medicine. While there is currently no solution for neurodegenerative conditions, researchers are constantly exploring novel therapeutic approaches. One such direction of research involves deschloroketamine, a derivative of the anesthetic ketami